loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 201922 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 MINOCYCLINE HYDROCHLORIDE (5)

filter

01 JOURNEY (5)

filter

01 CAPSULE, EXTENDED RELEASE;ORAL (5)

filter

01 EQ 112.5MG BASE (1)

02 EQ 135MG BASE (1)

03 EQ 45MG BASE (1)

04 EQ 67.5MG BASE (1)

05 EQ 90MG BASE (1)

filter

01 USA (5)

URL Supplier Web Content
CAPSULE, EXTENDED RELE...
EQ 135MG BASE
XIMINO
USA
201922
2012-07-11
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
EQ 90MG BASE
XIMINO
USA
201922
2012-07-11
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
EQ 45MG BASE
XIMINO
USA
201922
2012-07-11
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
EQ 112.5MG BASE
XIMINO
USA
201922
2012-07-11
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
EQ 67.5MG BASE
XIMINO
USA
201922
2012-07-11
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 201922

Looking for CTD TGA MCC DOSSIER APPLICATION 201922 5

19

JMC Corporation KR, based in South Korea, is a pharmaceutical company.

One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .

proudly manufactured in the

approval since 2012-07-11

JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 135MG BASE of MINOCYCLINE HYDROCHLORIDE.

18

JMC Corporation KR, based in South Korea, is a pharmaceutical company.

One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .

proudly manufactured in the

approval since 2012-07-11

JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 90MG BASE of MINOCYCLINE HYDROCHLORIDE.

17

JMC Corporation KR, based in South Korea, is a pharmaceutical company.

One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .

proudly manufactured in the

approval since 2012-07-11

JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 45MG BASE of MINOCYCLINE HYDROCHLORIDE.

16

JMC Corporation KR, based in South Korea, is a pharmaceutical company.

One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .

proudly manufactured in the

approval since 2012-07-11

JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 112.5MG BASE of MINOCYCLINE HYDROCHLORIDE.

15

JMC Corporation KR, based in South Korea, is a pharmaceutical company.

One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .

proudly manufactured in the

approval since 2012-07-11

JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 67.5MG BASE of MINOCYCLINE HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY